• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤类型影响恶性胸腔积液胸膜固定术的效果。

Tumor type influences the effectiveness of pleurodesis in malignant effusions.

机构信息

Pleural Diseases Unit, Department of Internal Medicine, University Hospital Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida, Avda Alcalde Rovira Roure 80, 25198 Lleida, Spain.

出版信息

Lung. 2011 Apr;189(2):151-5. doi: 10.1007/s00408-011-9283-6. Epub 2011 Feb 18.

DOI:10.1007/s00408-011-9283-6
PMID:21331598
Abstract

Pleurodesis is commonly indicated for symptom relief in patients with malignant pleural effusions. A number of factors may influence pleurodesis outcome, but whether tumor type is one of them is a matter of debate. This study investigates the impact of tumor type on the efficacy of bedside doxycycline and thoracoscopic talc poudrage pleurodesis in order to determine which patients may benefit most from these procedures. A retrospective study of 138 and 450 doxycycline and talc poudrage pleurodesis procedures, respectively, evaluated their overall successes and failures, according to primary tumor types. In addition, a logistic regression model addressed whether the pleurodesis outcome in different tumor types was influenced by or attributable to pleural tumor burden. In the talc group, patients with lung cancer and mesothelioma had significantly lower complete response rates (63 and 61%, respectively) as compared with breast (77%) and other metastatic effusions (74%, p = 0.012). In the doxycycline group, the data followed the same trend in that complete response rates were lower in patients with lung carcinomas (31%) than in those with breast cancer (54%) or metastases from other primary sites (74%, p = 0.001). The regression analysis showed pleural burden and tumor type as independent predictors of pleurodesis failure in the talc group. The tumor type involving the pleural surfaces influences the success of a pleurodesis, regardless of the sclerosing agent used. Malignant effusions due to mesothelioma and lung cancer are particularly prone to a failed procedure.

摘要

胸膜固定术常用于缓解恶性胸腔积液患者的症状。许多因素可能会影响胸膜固定术的结果,但肿瘤类型是否是其中之一存在争议。本研究调查了肿瘤类型对床边多西环素和胸腔镜滑石粉胸膜固定术疗效的影响,以确定哪些患者最有可能从这些手术中受益。对分别接受 138 例和 450 例多西环素和滑石粉胸膜固定术的患者进行回顾性研究,根据原发肿瘤类型评估其总体成功率和失败率。此外,使用逻辑回归模型探讨不同肿瘤类型的胸膜固定术结果是否受到或归因于胸腔内肿瘤负担的影响。在滑石粉组中,肺癌和间皮瘤患者的完全缓解率明显低于乳腺癌(77%)和其他转移性胸腔积液(74%)(p=0.012)。在多西环素组中,数据也呈现出相同的趋势,即肺癌患者的完全缓解率(31%)低于乳腺癌患者(54%)或其他原发性肿瘤转移患者(74%)(p=0.001)。回归分析显示,在滑石粉组中,胸腔内肿瘤负担和肿瘤类型是胸膜固定术失败的独立预测因素。涉及胸膜表面的肿瘤类型会影响胸膜固定术的成功率,而与使用的硬化剂无关。间皮瘤和肺癌引起的恶性胸腔积液尤其容易导致手术失败。

相似文献

1
Tumor type influences the effectiveness of pleurodesis in malignant effusions.肿瘤类型影响恶性胸腔积液胸膜固定术的效果。
Lung. 2011 Apr;189(2):151-5. doi: 10.1007/s00408-011-9283-6. Epub 2011 Feb 18.
2
Interventions for the management of malignant pleural effusions: a network meta-analysis.恶性胸腔积液管理的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3.
3
Interventions for the management of malignant pleural effusions: a network meta-analysis.恶性胸腔积液管理的干预措施:一项网状荟萃分析。
Cochrane Database Syst Rev. 2016 May 8;2016(5):CD010529. doi: 10.1002/14651858.CD010529.pub2.
4
Video-assisted thoracoscopic pleurodesis for malignant pleural effusions.电视辅助胸腔镜胸膜固定术治疗恶性胸腔积液
Acta Chir Hung. 1999;38(2):155-7.
5
Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.医疗胸腔镜和滑石粉胸膜固定术治疗恶性胸腔积液的成功率:单中心经验。
Respirology. 2018 Jun;23(6):613-617. doi: 10.1111/resp.13252. Epub 2018 Jan 10.
6
[Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].[胸腔镜滑石粉胸膜固定术治疗恶性胸腔积液:27例分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Dec 18;40(6):600-2.
7
Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.留置胸膜导管与滑石粉胸膜固定术对恶性胸腔积液患者住院天数的影响:AMPLE随机临床试验
JAMA. 2017 Nov 21;318(19):1903-1912. doi: 10.1001/jama.2017.17426.
8
Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.胸腔镜滑石粉胸膜固定术治疗恶性胸腔积液的临床疗效与安全性
Chest. 2005 Sep;128(3):1431-5. doi: 10.1378/chest.128.3.1431.
9
Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.滑石粉胸膜固定术可提高恶性胸腔积液患者的生存率:病例对照研究。
Wien Klin Wochenschr. 2015 Dec;127(23-24):963-9. doi: 10.1007/s00508-015-0716-8. Epub 2015 Apr 10.
10
Talc pleurodesis for the management of malignant pleural effusions in Japan.日本滑石胸膜固定术治疗恶性胸腔积液
Intern Med. 2013;52(11):1173-6. doi: 10.2169/internalmedicine.52.9281.

引用本文的文献

1
Relapsed Ovarian Cancer Patients with Ascites and/or Pleural Effusion Still Benefit from Treatment: A Real-Life Study.复发性卵巢癌伴腹水和/或胸腔积液患者仍可从治疗中获益:一项真实世界研究
Cancers (Basel). 2023 Dec 28;16(1):162. doi: 10.3390/cancers16010162.
2
Impact of Factors Secreted by Tumor Cells on Response of Pleural Mesothelial Cells to Different Sclerosing Agents in an In Vitro Model.肿瘤细胞分泌的因子对体外模型中胸膜间皮细胞对不同硬化剂反应的影响。
Med Sci Monit. 2022 May 10;28:e936065. doi: 10.12659/MSM.936065.
3
A multidirectional two-tube method for chemical pleurodesis could improve distribution of the sclerosing agent within the pleural cavity - A pilot study.

本文引用的文献

1
Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.恶性胸腔积液的管理:英国胸科学会胸膜疾病指南2010
Thorax. 2010 Aug;65 Suppl 2:ii32-40. doi: 10.1136/thx.2010.136994.
2
Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases.胸腔镜滑石粉注入术控制恶性胸腔积液后的早期和晚期发病率、死亡率及预期寿命:400例病例回顾
J Cardiothorac Surg. 2010 Apr 19;5:27. doi: 10.1186/1749-8090-5-27.
3
Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
一种用于化学性胸膜固定术的多向双管方法可改善硬化剂在胸腔内的分布——一项初步研究。
Ann Med Surg (Lond). 2021 Aug 9;68:102697. doi: 10.1016/j.amsu.2021.102697. eCollection 2021 Aug.
4
Influence of the progression of pleural neoplasia on the outcome of pleurodesis in mice.胸膜肿瘤进展对小鼠胸膜固定术结果的影响。
Oncotarget. 2020 May 26;11(21):2002-2009. doi: 10.18632/oncotarget.27610.
5
Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study.经隧道置入胸腔导管在恶性胸腔积液中实现成功且早期胸膜固定术的临床预测因素:一项队列研究
CMAJ Open. 2018 Jun 13;6(2):E235-E240. doi: 10.9778/cmajo.20170163. Print 2018 Apr-Jun.
6
Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.留置胸膜导管与滑石粉胸膜固定术对恶性胸腔积液患者住院天数的影响:AMPLE随机临床试验
JAMA. 2017 Nov 21;318(19):1903-1912. doi: 10.1001/jama.2017.17426.
7
Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol.氢氧化钠作为不能进行电视辅助胸腔镜手术(VATS)的肿瘤性胸腔积液患者的硬化剂:一项微创方案的结果
Updates Surg. 2018 Dec;70(4):535-544. doi: 10.1007/s13304-017-0485-1. Epub 2017 Aug 31.
8
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.表皮生长因子受体-酪氨酸激酶抑制剂(TKI)单独使用而不进行滑石粉胸膜固定术能否预防肺腺癌恶性胸腔积液(MPE)复发?
Curr Drug Discov Technol. 2016;13(2):68-76. doi: 10.2174/1570163813666160524142846.
9
Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer.内科胸腔镜滑石粉胸膜固定术治疗不同类型肿瘤及不同病理分型肺癌所致恶性胸腔积液的疗效
Int J Clin Exp Med. 2015 Oct 15;8(10):18945-53. eCollection 2015.
10
Successful use of central venous catheters in the management of recurrent malignant pleural effusions: one new option.中心静脉导管在复发性恶性胸腔积液管理中的成功应用:一种新选择。
Support Care Cancer. 2015 Aug;23(8):2267-71. doi: 10.1007/s00520-014-2595-3. Epub 2015 Jan 10.
床边滑石粉胸膜固定术治疗恶性胸腔积液:影响成功的因素
Ann Surg Oncol. 2009 Mar;16(3):745-50. doi: 10.1245/s10434-008-0263-x. Epub 2008 Dec 31.
4
Prognostic significance of pleural fluid data in patients with malignant effusion.恶性胸腔积液患者胸腔积液数据的预后意义
Eur J Intern Med. 2008 Jul;19(5):334-9. doi: 10.1016/j.ejim.2007.09.014. Epub 2007 Nov 8.
5
Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology.针对恶性病因导致的复发性胸腔积液的手术及其他侵入性治疗方法。
Support Care Cancer. 2008 Dec;16(12):1323-31. doi: 10.1007/s00520-008-0405-5. Epub 2008 Feb 8.
6
Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.滑石粉喷洒术与滑石粉浆治疗恶性胸腔积液的前瞻性对照研究。
Eur J Cardiothorac Surg. 2006 Dec;30(6):827-32. doi: 10.1016/j.ejcts.2006.10.002.
7
Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions.通过细导管注入强力霉素进行快速胸膜固定术治疗转移性恶性胸腔积液。
Support Care Cancer. 2006 May;14(5):475-8. doi: 10.1007/s00520-005-0001-x. Epub 2006 Jan 10.
8
Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.胸腔镜滑石粉胸膜固定术治疗恶性胸腔积液的临床疗效与安全性
Chest. 2005 Sep;128(3):1431-5. doi: 10.1378/chest.128.3.1431.
9
Thoracoscopy talc poudrage : a 15-year experience.胸腔镜滑石粉喷洒术:15年经验
Chest. 2001 Mar;119(3):801-6. doi: 10.1378/chest.119.3.801.
10
Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.预测复发性症状性恶性胸腔积液患者的生存率:对疾病范围的生理、形态学及生活质量指标的预后价值评估
Chest. 2000 Jan;117(1):73-8. doi: 10.1378/chest.117.1.73.